![A 60-year-old male with newly diagnosed prostate cancer (GS: 4+4, ISUP... | Download Scientific Diagram A 60-year-old male with newly diagnosed prostate cancer (GS: 4+4, ISUP... | Download Scientific Diagram](https://www.researchgate.net/publication/343629391/figure/fig3/AS:941394646540304@1601457382581/A-60-year-old-male-with-newly-diagnosed-prostate-cancer-GS-4-4-ISUP-grade-4-cT4-PSA.png)
A 60-year-old male with newly diagnosed prostate cancer (GS: 4+4, ISUP... | Download Scientific Diagram
![Towards the differential diagnosis of prostate cancer by the pre-treatment of human urine using ionic liquids | Scientific Reports Towards the differential diagnosis of prostate cancer by the pre-treatment of human urine using ionic liquids | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-71925-8/MediaObjects/41598_2020_71925_Fig1_HTML.png)
Towards the differential diagnosis of prostate cancer by the pre-treatment of human urine using ionic liquids | Scientific Reports
![Chemosensors | Free Full-Text | Novel Prostate Cancer Biomarkers: Aetiology, Clinical Performance and Sensing Applications Chemosensors | Free Full-Text | Novel Prostate Cancer Biomarkers: Aetiology, Clinical Performance and Sensing Applications](https://www.mdpi.com/chemosensors/chemosensors-09-00205/article_deploy/html/images/chemosensors-09-00205-g001.png)
Chemosensors | Free Full-Text | Novel Prostate Cancer Biomarkers: Aetiology, Clinical Performance and Sensing Applications
![Cancers | Free Full-Text | A Novel Urine Exosomal lncRNA Assay to Improve the Detection of Prostate Cancer at Initial Biopsy: A Retrospective Multicenter Diagnostic Feasibility Study Cancers | Free Full-Text | A Novel Urine Exosomal lncRNA Assay to Improve the Detection of Prostate Cancer at Initial Biopsy: A Retrospective Multicenter Diagnostic Feasibility Study](https://www.mdpi.com/cancers/cancers-13-04075/article_deploy/html/images/cancers-13-04075-g001.png)
Cancers | Free Full-Text | A Novel Urine Exosomal lncRNA Assay to Improve the Detection of Prostate Cancer at Initial Biopsy: A Retrospective Multicenter Diagnostic Feasibility Study
![Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management | Clinical Proteomics | Full Text Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management | Clinical Proteomics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12014-020-09305-7/MediaObjects/12014_2020_9305_Fig2_HTML.png)
Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management | Clinical Proteomics | Full Text
![InfoCancer - ARCAGY - GINECO - Localisations - Cancers masculins - Cancer de la prostate - Symptômes & diagnostic - Le bilan initial InfoCancer - ARCAGY - GINECO - Localisations - Cancers masculins - Cancer de la prostate - Symptômes & diagnostic - Le bilan initial](https://www.arcagy.org/infocancer/img/497_popup_toucher-rectal-0565209.jpg)
InfoCancer - ARCAGY - GINECO - Localisations - Cancers masculins - Cancer de la prostate - Symptômes & diagnostic - Le bilan initial
![Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients | Journal of Nuclear Medicine Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients | Journal of Nuclear Medicine](https://jnm.snmjournals.org/content/jnumed/62/9/1258/F1.large.jpg)
Head-to-Head Comparison of 68Ga-Prostate-Specific Membrane Antigen PET/CT and Ferumoxtran-10–Enhanced MRI for the Diagnosis of Lymph Node Metastases in Prostate Cancer Patients | Journal of Nuclear Medicine
![Cancers | Free Full-Text | Derivation and Application of Molecular Signatures to Prostate Cancer: Opportunities and Challenges Cancers | Free Full-Text | Derivation and Application of Molecular Signatures to Prostate Cancer: Opportunities and Challenges](https://www.mdpi.com/cancers/cancers-13-00495/article_deploy/html/images/cancers-13-00495-g001-550.jpg)
Cancers | Free Full-Text | Derivation and Application of Molecular Signatures to Prostate Cancer: Opportunities and Challenges
![Profiling the proteoforms of urinary prostate-specific antigen by capillary electrophoresis – mass spectrometry - ScienceDirect Profiling the proteoforms of urinary prostate-specific antigen by capillary electrophoresis – mass spectrometry - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1874391921000476-ga1.jpg)
Profiling the proteoforms of urinary prostate-specific antigen by capillary electrophoresis – mass spectrometry - ScienceDirect
![Frontiers | A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer Frontiers | A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer](https://www.frontiersin.org/files/Articles/1129140/fonc-13-1129140-HTML/image_m/fonc-13-1129140-g001.jpg)
Frontiers | A compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer
![Diagnostic performance of 18F-PSMA-1007 PET/CT in biochemically relapsed patients with prostate cancer with PSA levels ≤ 2.0 ng/ml | Prostate Cancer and Prostatic Diseases Diagnostic performance of 18F-PSMA-1007 PET/CT in biochemically relapsed patients with prostate cancer with PSA levels ≤ 2.0 ng/ml | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41391-019-0194-6/MediaObjects/41391_2019_194_Fig1_HTML.png)
Diagnostic performance of 18F-PSMA-1007 PET/CT in biochemically relapsed patients with prostate cancer with PSA levels ≤ 2.0 ng/ml | Prostate Cancer and Prostatic Diseases
![MAJOR LEAGUE BASEBALL AND PROSTATE CANCER FOUNDATION PARTNER ON 26TH ANNUAL HOME RUN CHALLENGE AND TOUR MAJOR LEAGUE BASEBALL AND PROSTATE CANCER FOUNDATION PARTNER ON 26TH ANNUAL HOME RUN CHALLENGE AND TOUR](https://mma.prnewswire.com/media/360219/prostate_cancer_foundation_logo.jpg?p=facebook)
MAJOR LEAGUE BASEBALL AND PROSTATE CANCER FOUNDATION PARTNER ON 26TH ANNUAL HOME RUN CHALLENGE AND TOUR
Native Mass Spectrometry Quantitation of α2-3-Linked N-Acetylneuraminic Acid Content of Prostate-Specific Antigen: An Accurate Liquid Biopsy for Clinically Significant Prostate Cancer | Analytical Chemistry
![Frontiers | Single-Center Evaluation of Treatment Success Using Two Different Protocols for MRI–Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer Frontiers | Single-Center Evaluation of Treatment Success Using Two Different Protocols for MRI–Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer](https://www.frontiersin.org/files/Articles/782546/fonc-11-782546-HTML/image_m/fonc-11-782546-g001.jpg)
Frontiers | Single-Center Evaluation of Treatment Success Using Two Different Protocols for MRI–Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer
![NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016 in: Journal of the National Comprehensive Cancer Network Volume 14 Issue 5 (2016) NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016 in: Journal of the National Comprehensive Cancer Network Volume 14 Issue 5 (2016)](https://jnccn.org/view/journals/jnccn/14/5/509fig03.jpeg)